Biochemistry Mycobacterium Tuberculosis Treated with Anti-Isoniazid Treatment
Published 2020-07-10
Keywords
- Mycobacterium tuberculosis,
- Isoniazid,
- Biochemistry
How to Cite
Abstract
Mycobacterium tuberculosis exposed to Isoniazid experienced drug resistance due to morphological and selection factors, with Isoniazid concentrations of 0.5 μg / ml with a contact time of 24 hours, 48 hours, 72 hours, 96 hours, the results obtained in testing for NaCl 5% Kruskal wallis obtained sig 0.005 results there is a treatment effect on growth While in the semi-quantitative catalase test, a sig value of 0.007 was obtained with p <0.01 so it can be concluded that there is a significant influence between the duration of isoniazid exposure. resistance occurs due to the selection of strains that are resistant to treatment during the therapy process at 96 hours exposure with a percentage of 2%. In the exposure process it can be concluded that it will change the resistance to 5% NaCl, changes in Catalase test results and also causes strain selection that is resistant to isoniazid 0.5 µg / ml.
References
- Asmar, S., Sassi, M., Phelippeau, M., and Drancourt, M. 2016. Inverse correlation between salt tolerance and host-adaptation in mycobacteria. BMC research notes, 9(1), 1-9. https://doi.org/10.1186/s13104-016-2054-y
- Babady, N. E., and Wengenack, N. L. 2012. Clinical laboratory diagnostics for Mycobacterium tuberculosis, understanding tuberculosis—global experiences and innovative approaches to the diagnosis. ISBN, 978-953.
- Boum, Y., Orikiriza, P., Rojas-Ponce, G., Riera-Montes, M., Atwine, D., Nansumba, M., Bazira, J., Tuyakira,E., De Beaudrap, P., Bonnet, M., and Page, A. L. 2013. Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings. Journal of Clinical Microbiology 51(7): 2273-2279. DOI: 10.1128/JCM.00749-13
- Conville, P. S., and Witebsky, F.G. 1998. Variables affecting results of sodium chloride tolerance test for identification of rapidly growing mycobacteria. Journal of Clinical Microbiology 36.6 : 1555-1559. DOI: 10.1128/JCM.36.6.1555-1559.1998
- Crofton, John, and D. A. Mitchison. 1948. Streptomycin resistence in pulmonary tuberculosis. British Medical Journal 2.4588 : 1009. doi: 10.1136/bmj.2.4588.1009
- Kochi, A., Vareldzis, B., and Styblo, K. 1993. Multidrug-resisten tuberculosis and its control. Research in microbiology, 144(2): 104-110. https://doi.org/10.1016/0923-2508(93)90023-U
- Larrouy-Maumus, G., Marino, L. B., Madduri, A. V., Ragan, T. J., Hunt, D. M., Bassano, L., Gutierrez, M.G., Moody, D.B., Pavan, F. R., and de Carvalho, L. P. S. 2016. Cell-Envelope Remodeling as a Determinant of Phenotypic Antibacterial Tolerance in Mycobacterium tuberculosis. ACS Infectious Diseases 2(5): 352-360. doi.org/10.1021/acsinfecdis.5b00148
- Ramaswamy, S. V., Reich, R., Dou, S. J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., and Graviss,A, 2003. Single nucleotide polymorphisms in genes associated with Isoniazid resistence in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 47 : 1241-1250. doi.org/10.1021/acsinfecdis.5b00148
- Widodo, W., Irianto, A., dan Pramono, H. 2017. Karakteristik Morfologi Mycobacterium tuberculosis yang Terpapar Obat Anti TB Isoniazid (INH) secara Morfologi. Majalah Ilmiah Biologi BIOSFERA: A Scientific Journal, 33(3), 109-115. Doi 10.20884/1.mib.2016.33.3.316
- Zhang, Y., Garbe, T., and Young, D. 1993. Transformation with Kat G restores Isoniazidâ€sensitivity in Mycobacterium tuberculosis isolates resisten to a range of drug concentrations. Molecular Microbiology, 8(3): 521-524. doi.org/10.1111/j.1365-2958.1993.tb01596.x
- Zhang, Y., Heym, B., Allen, B., Young, D., and Cole, S. 1992. The catalase—peroxidase gene and Isoniazid resistence of Mycobacterium tuberculosis, Nature, 358 (6387), 591 – 593. doi.org/10.1038/358591a0
- Zhang, Y., and Yew, W. W. 2009. Mechanisms of drug resistence in Mycobacterium tuberculosis [State of the art series. Drug-resisten tuberculosis. Edited by CY. Chiang. Number 1 in the series]. The International Journal of Tuberculosis and Lung Disease, 13(11): 1320-1330.
